ADVENTRX (AMEX: ANX) Pharmaceuticals Submits Their Anticipated Application
Just after some traders had given up on the company's promise to submit their New Drug Application (NDA) ADVENTRX announced on Monday that they had done just that.
| Small Cap Biotech Analysis |
Just after some traders had given up on the company's promise to submit their New Drug Application (NDA) ADVENTRX announced on Monday that they had done just that.
After re-examining the company's recent filings and reading carefully through the press-releases about the upcoming grand opening of their new Las Vegas facilities, it is hard to understand what some of these bears are seeing.
Our subscribers were alerted to this stock's breakout chart on December 16th when chares were selling for $.13 and it has traded up like clockwork ever since.
MCLN is on the rebound with a possible break-out on the radar screen.
Here's a closer look at the incredible trading activity for the two stocks we issued alerts on this week: Power3 Medical (OTC:PWRM) and Viking Systems (OTC:VKNG). Are the runs up done or is the table set for yet another push upwards?
Could PWRM easily become the next "Vermillion Dollar Baby?"
You can't go much further down than this. It looks like it's time to go higher from here.
Does this promising penny still have more room to run? You bet!
Some of the names on the list are small caps, but all of the companies are either biotechnology or pharmaceutical and they all meet other Index eligibility criteria.
Accusations are heating up in the drama involving Hemispherx Biopharma, Inc (AMEX:HEB) and the law firms trying to go after the well capitalized company on behalf of investors.